Palonosetron (Helsinn).

Name: Palonosetron (Helsinn).
Creator: Georg, Stacher
Keywords: Palonosetron, 03 medical and health sciences, Clinical Trials as Topic, Quinuclidines, Structure-Activity Relationship, 0302 clinical medicine, Animals, Antiemetics, Humans, Serotonin Antagonists

Georg, Stacher

Found an issue? Give us feedback

https://pubmed.ncbi....arrow_drop_down

https://pubmed.ncbi.nlm.nih.go...

Article . 2003

Data sources: Europe PubMed Central

Palonosetron (Helsinn).

descriptionPublicationkeyboard_double_arrow_right Article 11 Apr 2003 English Journal:Current opinion in investigational drugs (London, England : 2000), volume 3 (issn: 1472-4472,

Copyright policy )

Authors: Georg, Stacher;

pmid: 12431027

Palonosetron (Helsinn).

- Summary
- Subjects
- Metrics

Abstract

Palonosetron, a selective 5-HT3 receptor antagonist, is being developed by Helsinn for the potential treatment of chemotherapy-induced nausea and vomiting. By 1999, it was in phase III trials, and as of May 2002, an NDA filing was scheduled for the third quarter of 2002.

Related Organizations

University of Vienna
Austria

Keywords

Palonosetron, Clinical Trials as Topic, Quinuclidines, Structure-Activity Relationship, Animals, Antiemetics, Humans, Serotonin Antagonists, Isoquinolines

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average